Bayer AG said Friday that it would invest more than 1.3 billion euros ($1.44 billion) in its impact investment unit Leaps by Bayer throughout the following three years as it tries to drive innovation in the existence sciences domain.
The German drug and rural organization said it has previously invested more than EUR1.3 billion throughout the course of recent years in more than 50 organizations that emphasis on innovation in wellbeing and farming.
According to Bayer, “Impact Investment Unit is forthcoming influx of innovations will open new opportunities in cutting edge medical services and [provide] farming answers for make horticulture more sustainable and less asset intensive.” Chief Executive Werner Baumann said that Bayer would increase its determination in request to be a driver of this innovation.
Also Read: Nabs Wealth Management Leader Centura Wealth Advisory